tiprankstipranks
Trending News
More News >

SoftMedx Healthcare Reports Significant Financial Turnaround in 2024

Story Highlights
  • SoftMedx Healthcare reported a significant profit increase due to debt restructuring.
  • The company’s financial position improved from a net liability to net assets in 2024.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
SoftMedx Healthcare Reports Significant Financial Turnaround in 2024

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from China Wah Yan Healthcare ( (HK:0648) ).

SoftMedx Healthcare Limited reported its audited consolidated final results for the year ending December 31, 2024. The company achieved a significant profit before income tax of HK$327,954,000, a substantial increase from HK$14,369,000 in 2023, primarily due to a gain on debt restructuring. Despite a decrease in gross profit from HK$21,125,000 in 2023 to HK$18,398,000 in 2024, the company’s financial position improved markedly, with net assets of HK$2,456,000 compared to a net liability position of HK$323,861,000 the previous year. This financial turnaround indicates a positive impact on the company’s operations and potential strengthening of its market position.

More about China Wah Yan Healthcare

Current Market Cap: HK$123.9M

See more data about 0648 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1